viewer
Italy has temporarily stopped vaccination against the novel coronavirus infection (Corona 19) in a specific manufacturing unit developed by the multinational pharmaceutical company AstraZeneca.
The Italian Medicines Agency (AIFA) released a press release on the 11th (local time) and announced that it has decided to temporarily suspend the use of the AstraZeneca vaccine, whose manufacturing unit is’ABV2856′, nationwide.
AIFA said it has made this precautionary decision in connection with a recently reported suspected serious adverse event. However, it did not specifically mention the case. In response, ANSA news agency cited sources saying that AIFA’s decision was related to two fatalities in Sicily.
Reportedly, a 43-year-old man serving in the navy died of a heart attack at the dawn of the 10th, a day after the first dose of the AstraZeneca vaccine. A 50-year-old police officer in Sicily was reportedly killed late last month after getting the same vaccine. The policeman had a problem with his body just one day after vaccination. At the time, the doctor diagnosed thrombosis, which was reported to have led to complications such as cerebral hemorrhage, leading to death.
The Italian investigative authorities are investigating the exact details of the vaccine distribution officials and vaccination staff regarding the death case. AIFA stressed that to date, a causal relationship between these deaths and vaccination has not been identified. The Italian Prime Minister’s office said that the phone call between Italian Prime Minister Mario Draghi and European Union Commissioner Urzula Ponderaien highlighted that there was no relationship between the thrombosis cases reported in Europe and the AstraZeneca vaccination. The European Medicines Agency (EMA) has also reiterated its official position that the vaccine can continue while the investigation is under way, with no indication in its statement that the vaccination caused thrombosis.
A growing number of countries are discontinuing the use of the local AstraZeneca vaccine. In addition to Italy, only in Europe, Austria, Estonia, Latvia, Lithuania, Luxembourg, Denmark, Norway and Iceland have temporarily suspended the use of AstraZeneca’s specific manufacturing unit vaccine or the entire vaccine.
/ Reporter Kim Yeon-ha [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >